Skip to main content

Healthy Participant

5
Pipeline Programs
2
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
5
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 4 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
5 programs
5
PF-07220060Phase 11 trial
PF-07321332/ritonavirPhase 1Small Molecule1 trial
PF-07321332/ritonavirPhase 1Small Molecule1 trial
PF-07328948Phase 11 trial
prifetrastat ReferencePhase 11 trial
Active Trials
NCT07130097Completed35Est. Nov 2025
NCT04962230Completed12Est. Oct 2021
NCT04962022Completed12Est. Sep 2021
+2 more trials
Denali Therapeutics
Denali TherapeuticsCA - South SF
1 program
DNL919PHASE_1

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pfizerprifetrastat Reference
PfizerPF-07328948
PfizerPF-07220060
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir

Clinical Trials (5)

Total enrollment: 101 patients across 5 trials

NCT07721402Pfizerprifetrastat Reference

A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults

Start: Jul 2026Est. completion: Dec 202632 patients
Phase 1Recruiting

A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults

Start: Mar 2026Est. completion: Apr 202610 patients
Phase 1Completed

A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

Start: Aug 2025Est. completion: Nov 202535 patients
Phase 1Completed
NCT04962022PfizerPF-07321332/ritonavir

Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants

Start: Jul 2021Est. completion: Sep 202112 patients
Phase 1Completed
NCT04962230PfizerPF-07321332/ritonavir

Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

Start: Jul 2021Est. completion: Oct 202112 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 101 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.